Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many ...

From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

Russia's announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA technology shows potential, the lack of clinical data and the gap between ...

The ICMR has initiated the process of development of an ingenious human vaccine candidate against highly-pathogenic avian ...

TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...